United States Supreme Court
MedImmune, Inc. v. Genentech, Inc., 05-608
Dismissal of a drug manufacturer's patent and contract declaratory judgment action, for lack of subject-matter jurisdiction, is reversed where petitioner was not required, insofar as Article III is concerned, to break or terminate its 1997 license agreement before seeking a declaratory judgment in federal court that the underlying patent was invalid, unenforceable, or not infringed.
Appellate Information
- Decided 01/09/2007
- Published 01/09/2007
Judges
Court
- United States Supreme Court